Learn more about NCI's Provocative Questions Initiative
Save the Date: The Next Big Thing in Cancer Research
Did you know that MedImmune, Illumina, Affymetrix, and Accuray all received early stage technology funding from the NCI Small Business Innovation Research (SBIR) program? With $115 million in funding annually, NCI SBIR is one of the largest sources of early-stage funding for small businesses in the cancer space. We prospect for companies on the leading edge of innovation and provide them with the funding necessary to advance their technologies through development and towards commercialization.
If you're looking to tap into the next big thing in the cancer space, we encourage you to attend the NCI SBIR Investor Forum on April 18, 2012. The Investor Forum is an exclusive event designed to connect the strongest and most promising NCI SBIR companies with life science investors and strategic partners. In 2010, relationships established at the NCI SBIR Investor Forum resulted in more than $230 million in deals to advance companies on the cutting-edge of cancer technology development.
The agenda for the 2012 NCI SBIR Investor Forum is now available! Please click here to view the agenda.
Highlights of this full-day conference include:
- Get a sneak preview of the 18 leading NCI-SBIR funded oncology companies selected to present and learn about some of the leading innovations in cancer therapeutics, diagnostics, and devices primed for commercialization.
- Connect with 200 investors, venture capitalists, deal-makers, scientists, and small business leaders from the biotech and pharmaceutical industries.
- Engage in private breakout sessions and a networking reception with featured companies.
- Meet one-on-one with NCI leadership to gain new insights on funding and partnership opportunities and hear updates on new programs to accelerate promising cancer-related technologies to commercialization.
Registration is free, but limited. Investors and venture capitalists are invited to register today to reserve a space.
Following registration confirmation, investors and strategic partners are encouraged to schedule one-on-one meetings with the 18 SBIR selected companies presenting at the meeting. Investors, strategic partners, and presenting companies will receive login details via email to utilize the partnering website to schedule meetings in advance: http://ncisbirif.meeting-mojo.com/. As a reminder, your login is your email address. If you have forgotten your password, please visit: http://ncisbirif.meeting-mojo.com/request_password.
View highlights from the 2010 Investor Forum. Attendees included representatives from Kaiser, Takeda, and other industry leaders.
The National Cancer Institute SBIR Development Center in partnership with the Foundation for the National Institutes of Health (FNIH) and in collaboration with Prescience International. Learn more about our collaborators.
Check back soon for more updates and details on the 2012 NCI SBIR Investor Forum.
